Publications - Page 11 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Maladies pulmonaires chroniques kystiques (LAM/MKPM) 31/08/23
[Lung transplantation for lymphangioleiomyomatosis].

Reynaud-Gaubert M, Le Pavec J, Uzunhan Y.

Rev Mal Respir. 2023 Mar;40 Suppl 1:e62-e64.
Maladies pulmonaires chroniques liées à l’environnement 31/08/23
Basophil Activation Test With Aspergillus Molecules: The Case for ABPA.

Michel M, Sereme Y, Mankouri F, Gouitaa M, Gautier C, Mège JL, Cassagne C, Ranque S, Reynaud-Gaubert M, Vitte J.

Front Allergy. 2022 Jun 22;3:898731.
Maladies pulmonaires chroniques liées à l’environnement 31/08/23
Total unilateral pulmonary collapse secondary to allergic bronchopulmonary aspergillosis: a case series of an unusual cause of complete atelectasis.

Benkalfate N, Dirou S, Germaud P, Defrance C, Cavailles A, Pigeanne T, Robert M, Madjer T, Corne F, Cellerin L, Sagan C, Blanc FX.

BMC Pulm Med. 2021 Dec 24;21(1):425.
Maladies pulmonaires chroniques liées à l’environnement 31/08/23
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergy.

Vitte J, Michel M, Malinovschi A, Caminati M, Odebode A, Annesi-Maesano I, Caimmi DP, Cassagne C, Demoly P, Heffler E, Menu E, Nwaru BI, Sereme Y, Ranque S, Raulf M, Feleszko W, Janson C, Galán C; EAACI Task Force on Allergic Bronchopulmonary Aspergillosis.

Allergy. 2022 Nov;77(11):3199-3216.
Maladies pulmonaires chroniques liées à l’environnement 31/08/23
Basophil Activation Test With Aspergillus Molecules: The Case for ABPA.

Michel M, Sereme Y, Mankouri F, Gouitaa M, Gautier C, Mège JL, Cassagne C, Ranque S, Reynaud-Gaubert M, Vitte J.

Front Allergy. 2022 Jun 22;3:898731.
Maladies pulmonaires chroniques liées à l’environnement 31/08/23
Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?

Havette A, Regard L, Roche N, Burgel PR.

Eur Respir J. 2022 May 12;59(5):2102924.
Maladies pulmonaires chroniques liées à l’environnement 31/08/23
Eosinophilic Lung Diseases.

Cottin V.

Immunol Allergy Clin North Am. 2023 May;43(2):289-322.
Maladies pulmonaires chroniques liées à l’environnement 31/08/23
Allergic bronchopulmonary aspergillosis: A multidisciplinary review.

Roboubi A, Audousset C, Fréalle É, Brun AL, Laurent F, Vitte J, Mortuaire G, Lefevre G, Cadranel J, Chenivesse C.

J Mycol Med. 2023 Aug;33(3):101392.
Hypertension pulmonaire (HTP) 31/08/23
Routine Rehabilitation as a Treatment Component for Patients With Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertensions.

Barret T, Degano B, Bouvaist H, Pison C, Noirclerc M, Vanzetto G, Rocca C.

J Cardiopulm Rehabil Prev. 2023 Sep 1;43(5):354-360.
Hypertension pulmonaire (HTP) 31/08/23
Disruption of GCN2 Pathway Aggravates Vascular and Parenchymal Remodeling during Pulmonary Fibrosis.

Santos-Ribeiro D, Lecocq M, de Beukelaer M, Verleden S, Bouzin C, Ambroise J, Dorfmuller P, Yakoub Y, Huaux F, Quarck R, Karmouty-Quintana H, Ghigna MR, Bignard J, Nadaud S, Soubrier F, Horman S, Perros F, Godinas L, Pilette C.

Am J Respir Cell Mol Biol. 2023 Mar;68(3):326-338.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

[Lung transplantation for lymphangioleiomyomatosis].

Basophil Activation Test With Aspergillus Molecules: The Case for ABPA.

Total unilateral pulmonary collapse secondary to allergic bronchopulmonary aspergillosis: a case series of an unusual cause of complete atelectasis.

Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergy.

Basophil Activation Test With Aspergillus Molecules: The Case for ABPA.

Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?

Eosinophilic Lung Diseases.

Allergic bronchopulmonary aspergillosis: A multidisciplinary review.

Routine Rehabilitation as a Treatment Component for Patients With Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertensions.

Disruption of GCN2 Pathway Aggravates Vascular and Parenchymal Remodeling during Pulmonary Fibrosis.